UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~October~~November 3026, 2018

Aetna Inc.

(Exact name of registrant as specified in its charter)



Pennsylvania	1-16095	23-2229683
(State or other jurisdiction of	(Commission	(IRS Employer
incorporation)	File Number)	Identification No.)



151 Farmington Avenue, Hartford, CT	06156
(Address of principal executive offices)	(Zip Code)



Registrant's telephone number, including area code:	(860) 273-0123



Former name or former address, if changed since last report:	N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).



Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Section 28 -– ~~Financial~~Other ~~Information~~Events

Item 28.~~02 Results~~01 ofOther ~~Operations and Financial Condition~~Events.

On ~~October~~November 3026, 2018, Aetna Inc. ~~issued~~(“Aetna”) aand ~~press~~CVS ~~release~~Health ~~announcing~~Corporation ~~results~~(“CVS ~~for~~Health”) received the ~~third~~final ~~quarter~~regulatory ~~ended~~approval ~~September~~required ~~30,~~for ~~2018~~CVS Health to complete its acquisition of Aetna (the “CVS Health Transaction”). AThe ~~copy~~closing of ~~that~~the ~~press~~CVS ~~release~~Health Transaction is ~~furnished~~expected ~~herewith~~to asoccur ~~Exhibit~~on ~~99.1~~or ~~and~~about ~~hereby~~November ~~incorporated~~28, in2018, ~~this~~subject ~~Item~~to ~~2.02~~the bysatisfaction ~~reference~~of all other closing conditions.

~~The~~Cautionary ~~information~~Statement inRegarding ~~this Current Report on Form 8~~Forward-KLooking shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 927A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking ~~Financial~~statements ~~Statements~~by the use of forward-looking terminology such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “evaluate,” “expect,” “explore,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “view,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and ~~Exhibits~~involve known and unknown risks and uncertainties, many of which are beyond Aetna’s control.

~~Item~~Statements 9in this Current Report on Form 8-K that are forward-looking, including Aetna’s projection as to the timing of the closing of the CVS Health Transaction, are based on management’s estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of which are beyond Aetna’s control.~~01 Financial~~ ~~Statements~~Important risk factors could cause actual future results and ~~Exhibits~~other future events to differ materially from those currently estimated by management, including, but not limited to: the timing to consummate the CVS Health Transaction; the risk that a condition to the closing of the CVS Health Transaction may not be satisfied; and the diversion of and attention of management of both CVS Health and Aetna on transaction-related issues.

In addition, this Current Report on Form 8-K may contain forward-looking statements regarding Aetna’s business, financial condition and/or results of operations. These forward-looking statements also involve risks, uncertainties and assumptions, some of which may not be presently known to Aetna or that Aetna currently believes to be immaterial, that may cause Aetna’s actual results to differ materially from those expressed in the forward-looking statements and/or adversely impact Aetna’s businesses, CVS Health’s ability to complete the CVS Health Transaction, WellCare Health Plans, Inc.’s or its subsidiary’s (dcollectively, “WellCare’s”) ~~Exhibits~~ability to complete the acquisition of Aetna’s entire standalone Medicare Part D prescription drug plan business (the “Divestiture”) and/or CVS Health’s ability to realize the expected benefits from the CVS Health Transaction. Should any risks and/or uncertainties develop into actual events, these developments could have a material adverse effect on the CVS Health Transaction, the Divestiture and/or CVS Health or Aetna, CVS Health’s ability to successfully complete the CVS Health Transaction and/or realize the expected benefits from the CVS Health Transaction and/or WellCare’s ability to successfully complete the Divestiture. Additional information concerning the risks, uncertainties and assumptions described above can be found in Aetna’s filings with the SEC, including the risk factors discussed in “Item 1A. Risk Factors” in Aetna’s most recent Annual Report on Form 10‑K, as updated by Aetna’s Quarterly Reports on Form 10‑Q and future filings with the SEC.

~~The~~No ~~exhibit~~assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do occur, what impact they will have on the completion of the CVS Health Transaction and/or the Divestiture and/or Aetna’s results of operations, financial condition and/or cash flows. You are cautioned not to ~~this~~place ~~Current~~undue ~~Report~~reliance on ~~Form~~Aetna’s 8forward-Klooking isstatements. These forward-looking statements are and will be based on management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as ~~follows:~~of the dates of such statements. Aetna does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.

INDEX TO EXHIBITS

99.1 Press release of Aetna Inc. dated October 30, 2018 announcing results for the third quarter ended September 30, 2018

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	Aetna Inc.

Date: October 30, 2018	By:	/s/ Heather Dixon
Date: November 26, 2018	By:	/s/ Heather Dixon
		Name: Heather Dixon
		Title: Vice President, Controller and Chief Accounting Officer

Filing Compare · AETNA INC /PA/